AV
Artis Ventures (AV)
Venture CapitalActiveARTIS Ventures finances early-to-late stage venture investments and is based in San Francisco, California.
72
Investments
7
Exits
$2B
AUM
9.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Artis Ventures (AV).
Investment Thesis & Strategy
Artis Ventures invests in early-to-late stage fintech and venture capital companies, focusing on those based in San Francisco, California.
Investment Activity
Deals per year over the last 8 years
1
20140
20154
20162
20172
20181
20190
20202
2021Portfolio Companies
Selected investments from their portfolio of 72 companies
C
Cellino
Biotech · Series A, 2021
F
Form Bio
Biotech · Series A, 2021
U
Upside Foods
Food & Beverage · Series B, 2019
T
Tasso
Healthcare · Series A, 2018
M
MemVerge
Enterprise · Series B, 2018
X
Xometry
Enterprise · Series B, 2017
A
Aeva
Transportation · Series A, 2017
V
Vicarious Surgical
Healthcare · Series B, 2016
F
Freenome
Biotech · Series A, 2016
K
Karius
Healthcare · Series A, 2016
A
Alto Pharmacy
Healthcare · Series B, 2016
M
Modern Meadow
Biotech · Series B, 2014
Notable Exits
CompanyTypeYearValue / Acquirer
FreenomeAcquisition2024—
CellinoAcquisition2024—
Modern MeadowAcquisition2023—
StemIPO2022$1.3B
Planet LabsIPO2021$2.8B
Ginkgo BioworksIPO2021$15B
PalantirIPO2020$21.78B
Frequently Asked Questions
Artis Ventures (AV) focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Index Ventures
San Francisco, United States · 827 deals
First Round Capital
San Francisco, United States · 742 deals
Benchmark
San Francisco, United States · 600 deals
Founders Fund
San Francisco, United States · 564 deals
Matrix Partners
San Francisco, United States · 549 deals
Bain Capital Ventures
San Francisco, United States · 438 deals